[Non invasive fetal RhD genotyping using maternal blood: time for use in all RhD negative pregnant women]. / Génotypage RhD foetal non invasif sur sang maternel: vers une utilisation chez toutes les femmes enceintes RhD négatif.
Gynecol Obstet Fertil
; 36(2): 200-203, 2008 Feb.
Article
de Fr
| MEDLINE
| ID: mdl-18243756
ABSTRACT
Non invasive fetal RhD genotyping, based on polymerase-chain-reaction (PCR), is an accurate and validated technique. It allows a reduction by one-third of anti-D immunoglobulin injections to prevent RhD allo-immunization. In case of maternal anti-D immunization, fetal RhD genotyping allows to focus on RhD positive fetuses only the biologic and sonographic follow-up. The wide use of this technique implies the validation and economic evaluation of a commercial RhD genotyping kit, ready for use in non specialized laboratories.
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Diagnostic prénatal
/
Système Rhésus
/
Maladies foetales
Type d'étude:
Diagnostic_studies
Limites:
Female
/
Humans
/
Pregnancy
Langue:
Fr
Journal:
Gynecol Obstet Fertil
Sujet du journal:
GINECOLOGIA
/
OBSTETRICIA
Année:
2008
Type de document:
Article